Home / About the group / Visitors and news

Visitors and news


EMERGENCY: Coronavirus disease (COVID-19) Pandemic

16/03/2020
Regular updates on the coronavirus disease (COVID-19) outbreak are available at the WHO website.

New publication: Performance Indicators in Breast Cancer Screening in the European Union: A Comparison Across Countries of Screen Positivity and Detection Rates

13/03/2020
This is the first publication presenting adjusted breast cancer screening positivity and detection rates across Europe using data from the Second EU Screening Report. We documented large variability by country in detection rates at subsequent screening tests, likely due to differences in background risk, awareness of the target populations, and different screening protocols and organization. Periodic reporting of performance indicators permits comparisons and monitoring of the impact of screening programmes in EU-Member States. View the article.

Webinar: CanScreen5 in Latin America region

06/03/2020
The screening group organized in collaboration with Silvana Luciana from PAHO a virtual webinar with representatives from 12 Latin American countries (Argentina, Brazil, Chile, Colombia, Costa Rica, El Salvador, Honduras, Mexico, Nicaragua, Panama, Paraguay and Peru) to discuss the implementation of the CanScreen5 project and to study the barriers to cancer screening in the region.

Meeting: Developing the new guidelines for cervical cancer screening and treatment and Methodology Meeting, Montreux, Switzerland

02/03/2020 – 05/03/2020
Dr Partha Basu and Catherine Sauvaget participated to the WHO meeting of the WHO-Guideline Development Group on “Cervical Cancer Screening Recommendations”.

Video: Population-based trials on the safety, immunogenicity, efficacy and impact of human papillomavirus (HPV) vaccination, by professor Matti Lehtinen of the Karolinska Institutet (Stockholm, Sweden) and the Finnish Institute for Health and Welfare (Helsinki, Finland)

04/03/2020
Professor Matti Lehtinen of the Karolinska Institutet (Stockholm, Sweden) and the Finnish Institute for Health and Welfare (Helsinki, Finland) visited the International Agency for Research on Cancer (IARC) on 3 March 2020 and presented a seminar on “Population-based trials on the safety, immunogenicity, efficacy and impact of human papillomavirus (HPV) vaccination.” Watch video.

New publication: Peak neutralizing and cross-neutralizing antibody levels to human papillomavirus types 6/16/18/31/33/45/52/58 induced by bivalent and quadrivalent HPV vaccines.

03/03/2020
The Screening Group is delighted to present the findings of this independent comparison of neutralizing and cross-neutralizing antibody levels with the bivalent and quadrivalent HPV vaccines in Finnish and Indian adolescent populations. The correlation of bivalent vaccine-induced HPV45 ab-levels with HPV16/18 ab-levels was stronger than that of corresponding quadrivalent vaccine-induced ab-levels, suggesting a qualitatively different cross-reactive response. These findings on the comparison of the immunogenicity of two HPV vaccine tested in two different populations indicate that further head-to-head studies are warranted. View the article.

Internship: Laureline Guigon, University Lyon II, France

02/03/2020 – 31/07/2020
Mrs Guigon, Master in health and social psychology, has recently joined the screening group at IARC as a fellow. Laureline will be involved in the CANelles project. This project aims to develop a social network in breast cancer screening in France to be used as a Shared Decision Making tool for both women at the age of joining the breast cancer screening programme and General Practitioners.

Visit from the Hospital Israelita Albert Einstein, São Paulo, Brazil

17/02/2020 – 19/02/2020
The Screening Group (SCR) team participated in meetings with representative of the Sociedade Beneficente Israelita Brasileira Albert Einstein and the Einstein Friends of Oncology and Hematology (AMIGOH) to discuss mutual collaboration in areas of cancer prevention, screening, artificial intelligence, big data, development of Latin American Code Against Cancer and training opportunities.

WHO cancer strategy technical support mission, Beirut, Lebanon

10/02/2020 – 12/02/2020
Dr Partha Basu participated to the WHO-IARC-IAEA Cancer review Lebanon mission.

Conference: Harms and benefits of evidence-based screening outlined in new WHO report, Copenhagen, Denmark

11/02/2020 – 12/02/2020
Dr Andre Carvalho participated in this WHO-Euro conference on screening that was organized in the framework of a WHO European initiative aimed at improving decision-making related to screening practices to maximize benefits and minimize harms. .
View the meeting summary.

Next page     Last page

IARC, 150 Cours Albert Thomas, 69372 Lyon CEDEX 08, France - Tel: +33 (0)4 72 73 84 85 - Fax: +33 (0)4 72 73 85 75
© IARC 2020 - Terms of use  -  Privacy Policy.